Ellevest Inc. Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ellevest Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,208 shares of the medical equipment provider’s stock after buying an additional 53 shares during the period. Ellevest Inc.’s holdings in Intuitive Surgical were worth $1,152,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.5 %

Shares of NASDAQ:ISRG opened at $538.79 on Friday. The business has a 50-day moving average price of $501.36 and a 200-day moving average price of $534.58. The stock has a market cap of $193.11 billion, a price-to-earnings ratio of 84.05, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52-week low of $379.67 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the firm earned $1.50 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,313 shares of company stock valued at $17,229,143. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research note on Wednesday, April 23rd. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.